| Financial Year |
March 31 2023 |
| Monetary Funds |
313,986,184.64 |
| Held-for-trading Financial Assets |
115,000,000.00 |
| Notes Receivable |
435,596.35 |
| Accounts Receivable |
113,954,262.99 |
| Advances to Suppliers |
26,845,257.71 |
| Other Receivables |
7,283,509.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
319,190,450.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,489,075.93 |
| Total Current Assets |
923,600,483.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
147,661,131.04 |
| Under-construction Projects |
82,320,487.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
331,509,315.92 |
| R&D expenses |
-- |
| Goodwill |
509,584.29 |
| Long-Term Deferred and Prepaid Expenses |
5,220,366.90 |
| Deferred Income Tax Assets |
45,990,338.41 |
| Other Non-Current Assets |
13,100,005.29 |
| Sub-Total of Non-Current Assets |
640,397,759.37 |
| Total Assets |
1,563,998,242.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
204,416,308.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,770,288.78 |
| Taxes Payable |
9,524,203.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,741,225.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,908,181.66 |
| Other Current Liabilities |
6,140,442.40 |
| Sub-Total of Current Liabilities |
270,098,344.45 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,967,810.49 |
| Deferred Income Tax Liabilities |
2,682,392.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,356,024.79 |
| Total Liabilities |
300,454,369.24 |
| Paid-In Capital(Or Share Stock) |
131,522,720.00 |
| Capital Surplus |
750,237,756.36 |
| Surplus Reserve |
26,948,365.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
355,216,500.47 |
| Minority Stockholder's Interest |
-381,468.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,263,925,342.11 |
| Owner's Equity（Stockholder's Equity） |
1,263,543,873.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,563,998,242.46 |
